BENGALURU (Reuters) – Indian drugmaker Dr Reddy’s Laboratories Ltd will launch its generic version of Merck’s antiviral COVID-19 pill, molnupiravir, under brand name ‘Molflu’ and will price it at 35 rupees ($0.4694) per capsule, a company spokesperson said on Tuesday.
($1 = 74.5700 Indian rupees)
(Reporting by Anuron Kumar Mitra in Bengaluru; Editing by Shinjini Ganguli)
